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Edited by Barry HalliwellAbstract Uncoupling protein 2 (UCP2) is highly expressed in
the hypothalamus; however, little is known about the functions
it exerts in this part of the brain. Here, we hypothesized that
UCP2 protects hypothalamic cells from oxidative and pro-
apoptotic damage generated by inﬂammatory stimuli. Intra-
cerebroventricular injection of tumor necrosis factor alpha
(TNF-a)-induced an increase of UCP2 expression in the hypo-
thalamus, which was accompanied by increased expression of
markers of oxidative stress and pro-apoptotic proteins. The
inhibition of UCP2 expression by an antisense oligonucleotide
enhanced the damaging eﬀects of TNF-a. Conversely, increasing
the hypothalamic expression of UCP2 by cold exposure reversed
most of the eﬀects of the cytokine. Thus, UCP2 acts as a protec-
tive factor against cellular damage induced by an inﬂammatory
stimulus in the hypothalamus.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The uncoupling proteins (UCPs) are a family of anion-
carrier proteins expressed in the inner membrane of the mito-
chondria [1]. In brown adipose tissue, the prototypic UCP1
drives the leakage of protons from the intermembrane space
back to the mitochondrial matrix, wasting the electrochemical
gradient as heat [2]. During the last 10 years, four additional
UCP homologous proteins have been identiﬁed and shown
to be expressed in several tissues of the body, besides adipose
[1]. One of these homologues, uncoupling protein 2 (UCP2), is
highly expressed in the central nervous system, predominantly
in the hypothalamus, limbic system, cerebellum, choroid
plexus and brainstem [3]. Although, to a certain degree,Abbreviations: CAT, catalase; ICV, intracerebroventricular; IP, intra-
peritoneal; ROS, reactive oxygen species; SOD, superoxide dismutase;
TNF-a, tumor necrosis factor alpha; TUNEL, terminal deoxynucleo-
tidyl-transferase-mediated dUTP nick end-labeling; UCP2, uncoupling
protein 2
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doi:10.1016/j.febslet.2008.08.006UCP2 can exert a typical uncoupling and thermogenic func-
tion [4], the main role of this protein in the brain is still under
intense investigation [5]. There are a number of studies show-
ing that UCP2 may have a role in the control of neuronal
intracellular calcium, ATP production, mitochondrial biogen-
esis, synaptic transmission, neuronal plasticity and reactive
oxygen species (ROS) production [6].
Overproduction or accumulation of ROS in neurons is re-
garded as an important mechanism predisposing to the devel-
opment of neurodegenerative diseases [6]. The generation of an
increased mitochondrial membrane potential leads to a paral-
lel random single electron transfer reaction from components
of the electron transfer chain to molecular oxygen, boosting
the production of ROS [7]. Increasing the expression of
UCP2 in the mitochondria of neurons mitigates ROS produc-
tion, therefore protecting these cells from the damage from
oxidative stress [4].
The activation of inﬂammatory signaling is an important
mechanism leading to increased ROS production in several cell
types, including neurons [6]. The pro-inﬂammatory cytokine,
tumor necrosis factor alpha (TNF-a), is regarded as an impor-
tant mediator of neuronal damage in a number of inﬂamma-
tory and degenerative diseases of the central nervous system
[8]. One of the mechanisms involved in TNF-a-induced neuro-
nal damage is the overproduction of ROS [9,10].
In the present study, we tested the hypothesis that UCP2 can
act as an endogenous protective factor against inﬂammatory-
induced damage in the central nervous system. Our results
show that inhibiting UCP2 expression increases TNF-a-in-
duced expression of markers of ROS accumulation and apop-
tosis, while increasing UCP2 expression by cold exposure
restrains the damage caused by the cytokine.2. Materials and methods
2.1. Antibodies, chemicals and buﬀers
Reagents for SDS–PAGE and immunoblotting, HEPES, phenyl-
methylsulfonyl ﬂuoride, aprotinin, dithiothreitol, Triton X-100, Tween
20 and glycerol, were from Bio-Rad (Richmond, CA, USA). Sodium
thiopental was from Lilly (Indianapolis, IN, USA). Anti-UCP2
(sc-6525, goat polyclonal), anti-Bcl-2 (sc-492, rabbit polyclonal),
anti-Bax (sc-493, rabbit polyclonal), anti-actin (sc-7210, rabbit poly-
clonal), anti-cytochrome-c (sc-13561, mouse monoclonal), and anti-
superoxide dismutase 1 (SOD1) (sc-8637, goat polyclonal) antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-
catalase antibody (#C0979, mouse monoclonal) and hydroethidine
were from Sigma (St. Louis, MO, USA).ation of European Biochemical Societies.
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Male Wistar rats of 8–10 weeks (200–250 g) from the State Univer-
sity of Campinas Breeding Center, were used in the study. The inves-
tigation followed the University guidelines for the use of animals in
experimental studies and conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health (NIH publication no. 85-23, revised 1996). The animals were
maintained on a 12:12 h artiﬁcial light:dark cycle and housed in indi-
vidual cages. Standard rodent chow and water were provided ad libi-
tum.
2.3. Sense and antisense oligonucleotide treatment protocols
Sense and antisense oligonucleotides (produced by Invitrogen Corp.,
Carlsbad, CA, USA) were diluted to a ﬁnal concentration of 10 nmol/
ml in dilution buﬀer containing 10 mmol/l Tris–HCl and 1.0 mmol/l
EDTA. The rats were injected intraperitoneal (IP) with one daily dose
of 200 ll of dilution buﬀer containing, or not, sense (UCP2so) or anti-
sense oligonucleotides (UCP2aso). The oligonucleotides were designed
according to the UCP2 sequence deposited at the NIH-NCBI (http://
www.ncbi.nlm.nih.gov/entrez) under the designation NM 011671 and
were composed of 5 0-TGC ATT GCA GAT CTC A-3 0 (sense) and
5 0-TGA GAT CTG CAA TGC A-3 0 (antisense). The eﬀectiveness of
the oligonucleotides to inhibit UCP2 expression, has been previously
shown [11]. The treatment with the sense oligonucleotide produced
no diﬀerence in the expression of UCP2 as compared to control (data
not shown).
2.4. Intracerebroventricular (ICV) cannulation
Male Wistar rats were stereotaxically instrumented to receive a
cannula placed in the lateral ventricle, as previously described [12].
After 7 days, the correct location of the cannula was tested by injecting
2.0 ll angiotensin II (106 M) and determining the thirst response
[13].
2.5. TNF-a and cold exposure protocols
In a series of experiments, male Wistar rats were either maintained
at room temperature (22 C) or exposed to cold (4 C) for 9 days [14];
from day 3 on, groups at room temperature were sub-divided and trea-
ted ICV, at 9 a.m., either with saline or TNF-a (1012 M, 2.0 ll); at
the end of the experimental period (day 9) the animals were killed at
9 a.m. by deep anesthesia and the hypothalami prepared for further
analysis. This experiment was carried out ﬁve times. For another series
of four consecutive repeated experiments, age-matched male Wistar
rats were maintained at room temperature (22 C) and treated for 9
days with a single IP, daily dose of UCP2aso or dilution buﬀer; from
day 3 on, each group was sub-divided and treated ICV at 9 a.m. either
with saline or TNF-a (1012 M, 2.0 ll); at the end of the experimental
period (day 9) the animals were killed at 9 a.m. by deep anesthesia and
the hypothalami were prepared for analysis. Finally, in a series of four
consecutive repeated experiments, age-matched male Wistar rats were
either maintained at room temperature (22 C) or in a cold room
(4 C) and treated for 9 days with a single IP, daily dose of UCP2aso
or dilution buﬀer. All groups were subjected to one single ICV injec-
tion of TNF-a (1012 M, 2.0 ll), 24 h before hypothalamus prepara-
tion.
2.6. Hypothalamic specimen preparation for terminal deoxynucleotidyl-
transferase-mediated dUTP nick end-labeling (TUNEL)
Rats were submitted to deep anesthesia, the chest was opened, a nee-
dle was inserted into the left ventricle, and the descending aorta was
opened. Whole body perfusion involved sequential injections of 0.9%
saline solution (until the blood was washed out), followed by 4% para-
formaldehyde for 30 min. The rats were then decapitated; the whole
brain was removed, and stored overnight at 4 C in a vial containing
4% paraformaldehyde. Coronal sections were carried out beginning
anterior to the optic chiasm and spanning the hypothalamus up to
the region posterior to the mammillary peduncle. The portion contain-
ing the hypothalamus was paraﬃn-embedded and manually sectioned
(5.0 lm) using a Leica RM2125 microtome (Wetzlar, Germany). Sec-
tions were placed on Vectabond reagent processed glass slides (Vector
Laboratories, Burlingame, CA, USA) and air-dried overnight at room
temperature. Sections were deparaﬃnized in xylene (three washes), fol-
lowed by rehydration in decreasing concentrations (100%, 95% and
70%) of ethanol.2.7. Detection of apoptosis of hypothalamic cells by TUNEL
A TUNEL assay was used to identify double-stranded DNA frag-
mentation. Brieﬂy, tissue slides after deparaﬃnization, were treated
with proteinase K (20 lg/ml) for 15 min at room temperature, and then
quenched in 2.0% hydrogen peroxide. After rinsing in phosphate-buf-
fered saline (PBS), pH 7.4, specimens were incubated in 1· equilibra-
tion buﬀer for 10–15 s. The slides were then incubated with terminal
deoxynucleotidyl transferase (TdT) for 1 h at 37 C, blocked with
stop/wash buﬀer, and incubated with peroxidase antibody for 30 min
at room temperature. The TUNEL assay negative control consisted
of staining the tissues in the same manner without the antibody. The
percentage of TUNEL-positive cells in lateral hypothalamus was
determined in ﬁve non-consecutive sections obtained from each tissue
block (n = 5).
2.8. Detection of apoptosis of hypothalamic cells by the annexin method
Rats were submitted to deep anesthesia, the chest was opened, a nee-
dle was inserted into the left ventricle, and the descending aorta was
opened. Whole body perfusion involved sequential injections of 0.9%
saline solution, until the blood was washed out. After decapitation,
the brain was rapidly removed and deep-frozen in liquid nitrogen. Five
micrometers sections were obtained from regions located between
bregma 0.0 and5.0 mm. The sections were incubated with FITC-con-
jugated annexin V (1:500) in a dark chamber. After washing, the slides
were mounted and evaluated by ﬂuorescence microscopy.
2.9. Detection of O2 and O2 derived oxidant production
Two hundred microliters of PBS containing 1.0 lg/ll hydroethidine
were injected IP and after 15 min the hypothalami were harvested, fro-
zen on dry ice and sectioned in 14 lm thick sections. After mounting in
gelatin-coated slides, ethidium accumulation was evaluated by ﬂuores-
cence microscopy (excitation, 510 nm; emission 580 nm). Results are
presented as direct comparison between groups. Detailed description
of the method was originally published by Wu et al. [15].
2.10. Mitochondria preparation for use in immunoblot experiments
Hypothalamic mitochondria were isolated by homogenization in ice-
cold medium containing 100 mmol/l sucrose, 100 mmol/l KCl,
50 mmol/l Tris–HCl, 1.0 mmol/l K2HPO4, 0.1 mmol/l EGTA, and
0.2% BSA, pH 7.4, followed by diﬀerential centrifugation, as described
[16]. Samples containing 80 lg mitochondria protein were separated by
SDS–PAGE, transferred to nitrocellulose membranes, and blotted
against UCP2, Bax, Bcl-2 and cytochrome-c antibodies. The quality
of the mitochondria preparation was evaluated by the determination
of in vitro respiration, as previously described [16].
2.11. Immunoblotting
Hypothalami were excised and immediately homogenized in solubi-
lization buﬀer at 4 C [1% Triton X-100, 100 mmol/l Tris–HCl (pH
7.4), 100 mmol/l sodium pyrophosphate, 100 mmol/l sodium ﬂuoride,
10 mmol/l EDTA, 10 mmol/l sodium orthovanadate, 2.0 mmol/l
PMSF and 0.1 mg aprotinin/ml] with a Polytron PTA 20S generator
(model PT 10/35; Brinkmann Instruments, Westbury, NY, USA).
Insoluble material was removed by centrifugation for 40 min at
11000 rpm in a 70 Ti rotor (Beckman, Fullerton, CA, USA) at 4 C.
The protein concentration of the supernatants was determined by the
Bradford dye binding method. In direct immunoblot experiments,
80 lg of protein extracts obtained from hypothalamus were separated
by SDS–PAGE, transferred to nitrocellulose membranes, and blotted
with antibodies against UCP2, catalase (CAT), superoxide dismutase
(SOD) and actin.
2.12. Immunohistochemistry
Paraformaldehyde-ﬁxed hypothalami were sectioned (5.0 lm) and
used in regular single-immunoﬂuorescence staining using UCP2 anti-
bodies as previously described [11]. Analysis and documentation of re-
sults were performed using a Leica FW 4500 B microscope (Wetzlar,
Germany). The hypothalami were sectioned fromBregma1.8 to3.6.
2.13. Statistical analysis
Speciﬁc protein bands present in the blots were quantiﬁed by digital
densitometry (ScionCorp Inc., Frederick, MD, USA). Mean val-
ues ± S.E. obtained from densitometric scans, and numeric data from
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ANOVA with Bonferroni post-test and t-test. A P value of <0.05 was
accepted as statistically signiﬁcant.3. Results
3.1. TNF-a induces apoptosis in hypothalamus
The ability of TNF-a to induce apoptosis in the hypothala-
mus was studied by means of two diﬀerent methods. First, a
group of ﬁve rats were treated for 6 days with a single dose
(2.0 ll, 1012 M) of TNF-a and, at the end of the experimentalFig. 2. Evaluation of mitochondrial preparation and UCP2 expression. (A) R
rat hypothalami treated with saline (CT), TNF-a (1012 M; single ICV injecti
UCP2 expression was analyzed by immunoblot in puriﬁed mitochondria pr
(WAT) and the heart. In the right-hand side panels, UCP2 expression w
hypothalamus (Hypoth), white adipose tissue (WAT) and heart (n = 4);
mitochondria) and anti-actin antibodies (for whole tissue extract). (C) UC
injection/day) with UCP2 antisense oligonucleotides (UCP2aso) in the follow
were immunoblotted with anti-UCP2 and anti-cytochrome-c antibodies (n = 4
paraformaldehyde ﬁxed hypothalami of control (CT) or UCP2 antisense olig
rats. (E) Determination of UCP2 expression in hypothalami of rats maintaine
days and 6 days, samples were immunoblotted with anti-UCP2 or anti-cyto
CT).
Fig. 1. Detection of apoptosis of hypothalamic cells. (A) Analysis of
TUNEL-positive staining (cells/ﬁeld) of animals treated either with
TNF-a (1012 M) or saline (CT). Values are means ± S.E.M., of ﬁve
distinct observations (*P < 0.05 vs. CT). (B) Representative annexin
stained sections of rat hypothalamus. Upper panels, low magniﬁcation
(50·), depicting third ventricle (3v) and surrounding nuclei at Bregma
2.6. Lower panels, high magniﬁcation (200·) depicting the arcuate
nucleus. Rats were treated ICV either with TNF-a or saline (CT)
(n = 5).period, the hypothalami were obtained and used for analysis
by the TUNEL method. As shown in Fig. 1A, TNF-a pro-
moted a 2.2-fold increase in TUNEL-positive cells. Next, an-
other group of ﬁve rats were treated, according to the same
protocol as above, and at the end of the experimental period,
freshly removed specimens were evaluated by the annexin V
method. The semi-quantitative evaluation revealed a signiﬁ-
cant diﬀerence in annexin V-positive cells between control
and TNF-a-treated rats, as shown in Fig. 1B.
3.2. Modulation of UCP2 expression in hypothalamus
Initially, the quality of the mitochondria preparation was
evaluated by determining the eﬀects of TNF-a and cold expo-
sure on the respiration pattern of isolated mitochondria. As
depicted in Fig. 2A, both the ICV TNF-a treatment and the
exposure of experimental animals to +4 C led to a signiﬁcant
fall in the respiratory rates of the isolated mitochondria, a ﬁnd-
ing that is in accordance with previous studies [17]. Next, we
determined the capacity of detecting UCP2 expression by the
immunoblot technique. As shown in Fig. 2B, UCP2 could be
easily detected in isolated mitochondria from hypothalamus
and white adipose tissue, but not from the heart of rats. Using
whole tissue extracts, the sensibility of the method was much
lower (Fig. 2B, right-hand side panel). Therefore, in the
remainder of the experiments designed to evaluate UCP2
expression (and also Bax and Bcl-2 expression), only hypotha-
lamic puriﬁed mitochondria preparations were used. To reduce
UCP2 expression, rats were treated for 9 days with a single IP
dose (dose response ranging from 0.0 to 2.0 nmol/day) of UC-
P2aso. As shown in Fig. 2C, the doses of 1.0 and 2.0 nmol/day
were capable of inhibiting most of the expression of the immu-
noreactive UCP2 in isolated mitochondria. The eﬀect of the
antisense oligonucleotide (2.0 nmol/day) to reduce UCP2
expression was further conﬁrmed by immunoﬂuorescenceespiratory rates (nmol O2/ml) of puriﬁed mitochondria preparations of
on) or by cold exposure (4 C) (n = 3). (B) In the left-hand side panels,
eparations from the hypothalamus (Hypoth), the white adipose tissue
as analyzed by immunoblot in the whole tissue extracts (WTE) of
loading controls were blotted with anti-cytochrome-c (Cyt-c) (for
P2 expression was analyzed in rats pre-treated (for 9 days, single IP
ing concentrations: 0, 0.5, 1.0 and 2.0 nmol/day, respectively; samples
). (D) Anti-UCP2 immunohistochemical staining of 5.0 lm sections of
onucleotide treated (2.0 nmol/day, for 9 days, single IP injection/day)
d at room temperature (22 C) or exposed to cold (4 C) during 24 h, 3
chrome-c antibodies (n = 4). Values are means ± S.E.M. (*P < 0.05 vs.
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(Fig. 2D). Thus, in the remainder of the experiments aimed
at inhibiting the expression of UCP2, the dose of 2.0 nmol/
day was always employed. Finally, to increase UCP2 expres-
sion in hypothalamus, we exposed the experimental animals
to a cold environment. As shown in Fig. 2E, after three and,
particularly, after 6 days of cold exposure a remarkable incre-
ment in UCP2 expression in mitochondria from hypothalamic
cells was observed.
3.3. UCP2 expression inhibition increases TNF-a-induced
apoptosis and ROS accumulation in the hypothalamus
In rats treated ICV with TNF-a, the expression of UCP2 in
hypothalamic mitochondria was increased by approximatelyFig. 3. Modulation of UCP2 (A), Bax (B) and Bcl-2 (C) expressions in hypo
hypothalamus extract of untreated rats (CT), rats treated with TNF-a, or
oligonucleotides (TNF + UCP2aso). Samples were obtained from rats treated
or TNF-a (1012 M; single ICV injection) plus UCP2 anti-sense oligonucleot
Cytochrome-c (Cyt-c) or actin were analyzed as loading controls. (D) Detectio
positive staining (cells/ﬁeld) in saline treated, TNF-a-treated rats and TNF-
aso). (G) Fluorescence microscopy of 14 lm thick sections from hypothalam
ethidium was detected by excitation, 510 nm and emission 580 nm (magniﬁca
n = 5; *P < 0.05 vs. CT, §P < 0.05 vs. TNF); G, depicts typical acquisitions otwo-fold, as compared to the control (Fig. 3A). The use of
the UCP2 antisense oligonucleotide signiﬁcantly inhibited the
eﬀect of TNF-a, maintaining the levels of immunoreactive
UCP2 similar to that of the control. Under UCP2 inhibition,
the eﬀects of TNF-a on markers of apoptosis were signiﬁcantly
magniﬁed. First, TNF-a-induced an approximately three-fold
increase in the hypothalamic expression of the pro-apoptotic
protein Bax (Fig. 3B), while in UCP2-inhibited rats, the eﬀect
of TNF-a was signiﬁcantly increased, reaching an almost ﬁve-
fold increase as compared to control and a 1.5-fold increase as
compared to TNF-a treatment alone (Fig. 3B). Regarding the
anti-apoptotic protein Bcl-2, TNF-a alone produced a signiﬁ-
cant reduction, leading to levels that corresponded to 50% of
control levels (Fig. 3C). The inhibition of UCP2 expression sig-thalamic mitochondria and SOD (E) and catalase (CAT) (F) in whole
rats treated with TNF-a and previously exposed to UCP2 antisense
, ICV, either with saline (CT), TNF-a (1012 M; single ICV injection),
ides during 9 days, (2.0 nmol/day, single IP injection/day), respectively.
n of apoptosis in hypothalamic cells by TUNEL. Analysis of TUNEL-
a-treated rats pre-exposed to UCP2 antisense oligonucleotides (UCP2
us (arcuate nucleus, Bregma 2.6) of rats treated with hydroethidin;
tion, 400·). Values are means ± S.E.M. (in A–C, E and F, n = 4; in D,
f n = 3.
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60% reduction in Bcl-2, as compared to TNF-a only. This cor-
responds to approximately 20% of the levels of Bcl-2 detected
in the hypothalamic mitochondria of control rats (Fig. 3C). In
parallel to the eﬀects of UCP2 inhibition on Bax and Bcl-2, an
eﬀective modulation of apoptosis was detected. As shown in
Fig. 3D, TUNEL-positive cells in the hypothalamus of TNF-
a plus UCP2aso increased by more than two-fold, as com-
pared to TNF-a-treated only rats, and by approximately
four-fold, as compared to controls. Since apoptosis induced
by pro-inﬂammatory cytokines can be mediated, at least in
part, by ROS accumulation, we determined the expression of
two important markers of ROS production, SOD and CAT.
As shown in Fig. 3E and F, TNF-a alone signiﬁcantly in-
creased the expressions of both enzymes (2- and 1.5-fold for
SOD and CAT, respectively), an eﬀect that was signiﬁcantly
magniﬁed by the simultaneous inhibition of UCP2 (1.5- and
1.7-fold for SOD and CAT, respectively). Moreover, TNF-a
was also capable of inducing an increased hypothalamic accu-
mulation of ethidium in hydroethidin treated rats, an eﬀect
that was further enhanced by the inhibition of UCP2 expres-
sion (Fig. 3G).
3.4. Cold-exposure simultaneously increases hypothalamic
UCP2 expression and protects cells from TNF-a-induced
apoptosis
In TNF-a-treated rats, the exposure to cold produced a 2.2-
fold increase in hypothalamic UCP2 expression, as compared
to controls, and a 1.4-fold increase, as compared to TNF-a
treatment alone (Fig. 4A). This eﬀect was accompanied by a
signiﬁcant reduction in Bax expression (30% of TNF-a-trea-
ted only) to levels similar to those of the controls (Fig. 4B), andFig. 4. Modulation of UCP2 (A), Bax (B) and Bcl-2 (C) expressions in hypo
hypothalamus extract of untreated rats (CT), rats treated with TNF-a, or rat
obtained from rats treated, ICV, either with saline (CT), TNF-a (1012 M; sin
exposure for 9 days, respectively. Cytochrome-c (Cyt-c) or actin were analyze
by TUNEL. Analysis of TUNEL-positive staining (cells/ﬁeld) in saline treate
days. Values are means ± S.E.M. (in A–C, E and F, n = 4; in D, n = 5; *P <to a signiﬁcant increase in Bcl-2 expression (1.5-fold, as com-
pared to TNF-a-treated only) to levels similar to control, as
well (Fig. 4C). The evaluation of apoptosis by TUNEL re-
vealed that cold exposure was suﬃcient to completely inhibit
TNF-a-induced apoptosis (Fig. 4D). Finally, cold exposure
partially restored the levels of SOD and CAT, leading to levels
40% and 55% of TNF-a-treated only rats, respectively (Fig.
4E and F). However, the levels of the enzymes were still signif-
icantly higher than in controls (Fig. 4E and F).
3.5. Inhibition of UCP2 expression restrains the protective
eﬀects of cold exposure in markers of cell damage
To determine the role played by the increased expression of
UCP2 in cold-exposed animals, regarding the damaging eﬀects
of TNF-a, a group of rats exposed to cold were treated with the
antisense oligonucleotide to inhibit UCP2 expression and the
expressions of Bax, SOD and CAT were evaluated. As shown
in Fig. 5A, the treatment of cold-exposed/TNF-a-treated rats
with UCP2 antisense oligonucleotide signiﬁcantly reduced
UCP2 expression to 45% of that seen in cold-exposed/TNF-a-
treated only rats. Under UCP2 expression inhibition, a com-
plete reversal of the protective eﬀect of cold exposure upon
Bax expression was obtained (Fig. 5B). Similarly, the levels of
SOD (Fig. 5C) and CAT (Fig. 5D) were completely reversed
to those of rats treated with TNF-a but not exposed to cold.4. Discussion
Several cell types and tissues are known to be sensitive to
prolonged inﬂammatory stimuli, undergoing apoptosis [18].
In the nervous system, apoptosis induced by continuousthalamic mitochondria and SOD (E) and catalase (CAT) (F) in whole
s treated with TNF-a and exposed to cold (TNF + 4 C). Samples were
gle ICV injection), or TNF-a (1012 M; single ICV injection) plus cold
d as loading controls. (D) Detection of apoptosis in hypothalamic cells
d, TNF-a-treated rats and TNF-a-treated rats plus cold exposure for 9
0.05 vs. CT, §P < 0.05 vs. TNF).
Fig. 5. Modulation of UCP2 (A) and Bax (B) expressions in
hypothalamic mitochondria and SOD (C) and catalase (CAT) (D) in
whole hypothalamus extracts of rats exposed either to TNF-a, TNF-a
plus cold exposure (TNF + 4 C), and TNF-a plus cold exposure in
rats pre-treated with UCP2 antisense oligonucleotides
(TNF + 4 C + UCP2aso). Samples were collected from rats treated
with TNF-a (1012 M; single ICV injection), or TNF-a (1012 M;
single ICV injection) plus cold exposure for 9 days, or TNF-a
(1012 M; single ICV injection) plus cold exposure for 9 days plus
UCP2 anti-sense oligonucleotides during the 9 days, (2.0 nmol/day,
single IP injection/day); cytochrome-c (Cyt-c) or actin were used as
loading controls. Values are means ± S.E.M (n = 4; *P < 0.05 vs. TNF;
§P < 0.05 vs. TNF + 4 C).
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erative diseases such as Alzheimers disease, Parkinsons dis-
ease, epilepsy and amyotrophic lateral sclerosis [19,20]. Once
installed, independently of its source, inﬂammation can disturb
cellular homeostasis by multiple mechanisms [21]. Local pro-
duction and action of inﬂammatory cytokines is regarded as
one of the most important mechanisms linking inﬂammation
to apoptosis [22,23]. The ﬁnal fate of a given cell exposed to
a pro-apoptotic stimulus depends not only on the type and
magnitude of the stimulus, but also on the intrinsic capacity
of the cell to resist the challenge. Recently, a number of studies
have provided strong evidence to support a role for UCP2 as a
protective factor against neuronal damage [4,24]. One of the
proposed mechanisms for the eﬀect of UCP2 is the control
of ROS production [25]. Here, we tested the hypothesis that
UCP2 acts as an endogenous protective factor against TNF-
a-induced cell damage.
Initially, the capacity of TNF-a to induce apoptosis in the
hypothalamus was tested. For this, ICV cannulated rats were
treated for 6 days with a low dose of the cytokine and apopto-
sis was evaluated by two distinct methods. As previously dem-
onstrated in a number of studies using both cells and intact
tissues from several regions of the brain, in our hands, TNF-
a produced an outstanding response, increasing the number
of apoptotic cells in the hypothalamus [26,27].Since our working hypothesis is that UCP2 expression
would protect cells from TNF-a-induced damage, we next
optimized the methods for detection of UCP2 in the hypothal-
amus. First, we evaluated the quality of the mitochondria
preparation. For this a mitochondria respiration assay was set-
tled and the eﬀects of both TNF-a and cold exposure, reducing
the respiratory rates of hypothalamic mitochondria and con-
ﬁrming the adequate experimental conditions, were deter-
mined. Next, during the optimization of the methods for
detecting UCP2 expression, we observed that, although a pro-
tein band corresponding to UCP2 could be detected in whole
tissue extracts, a considerably better result was obtained when
working with proteins from isolated mitochondria. By employ-
ing this method, we established the optimal conditions for
inhibiting UCP2 expression, using a previously described anti-
sense oligonucleotide [11], and for increasing UCP2 expres-
sion, by exposing the experimental animals to a cold
environment, as previously optimized [28].
To evaluate the role of UCP2 as a protective factor against
TNF-a-induced damage in the hypothalamus, rats were trea-
ted simultaneously with TNF-a and with the antisense oligo-
nucleotide against UCP2. First, we observed that ICV TNF-
a alone induced a more than two-fold increase in UCP2
expression in the hypothalamus. Studies from the late 1990s
explored the inﬂammatory mechanisms capable of inducing
the expression of UCP proteins in several tissues. According
to these studies, TNF-a is an important mediator of the eﬀects
of LPS towards UCP gene transcription, and proposed that
this eﬀect of TNF-a would be one of the mediators of inﬂam-
mation and infection-induced fever [29]. When we used the
antisense oligonucleotide, UCP2 protein was reduced to levels
below those of the control. This fact resulted in increased
expression of the pro-apoptotic protein, Bax, and reduced
expression of the anti-apoptotic Bcl-2, and coincided with in-
creased apoptosis in hypothalamus, as determined by the
TUNEL method. This is the ﬁrst evidence of a protective eﬀect
of UCP2 in TNF-a-induced apoptosis in nervous tissue. It may
explain for example, some of the protective eﬀects of UCP2 in
stroke and trauma and provides further support for the pro-
posed anti-apoptotic eﬀects of UCP2 in peripheral tissues
[30,31].
Since the inhibition of ROS production is believed to be one
of the most important mechanisms involved in UCP2-depen-
dent neuronal protection, we evaluated the impact of UCP2
inhibition on TNF-a-induced SOD and CAT expression and
on ethidium accumulation following hydroethidin treatment.
TNF-a alone produced an approximately two-fold increase
in SOD and CAT expression in the hypothalamus. In isolated
neural cells [32] and in peripheral cells and tissues, TNF-a has
been exhaustively shown to stimulate the expression of these
enzymes. When UCP2 was inhibited, the expressions of both
enzymes were signiﬁcantly increased, strongly suggesting that
at least part of the damaging eﬀect of reduced UCP2 expres-
sion was linked to increased ROS production. Indeed, when
employing a method that indirectly estimates O2 and O2 de-
rived oxidant production by determining the local accumula-
tion of ethidium, an oxidized product of hydroethidin,
similar results were found.
As an indirect means of evaluating the eﬀect of increased
UCP2 expression in TNF-a-induced damage of hypothalamic
cells, rats were exposed to cold and then treated with the cyto-
kine. The exposure to cold alone promoted a signiﬁcant in-
G.R. Degasperi et al. / FEBS Letters 582 (2008) 3103–3110 3109crease in UCP2 expression and, when comparing TNF-a treat-
ment alone with TNF-a plus cold exposure, the diﬀerence in
UCP2 protein level was about 1.4-fold. In parallel to the eﬀect
of cold on UCP2 expression, a remarkable inhibition of Bax
and a stimulation of Bcl2 plus a signiﬁcant inhibition of apop-
tosis was observed. All these eﬀects were accompanied by a
reduction in the expression of the enzymes SOD and CAT.
Therefore, cold exposure is capable of signiﬁcantly reducing
the damaging eﬀects of TNF-a in cells of the hypothalamus.
The ability of cold exposure to induce the expression of
UCP2 in neural tissue is already known [33]; however, this is
the ﬁrst report of a synergic eﬀect of a cytokine and cold expo-
sure to increase the expression of UCP2. Cold exposure can
modulate the expression of a number of diﬀerent proteins in
the hypothalamus, as shown in some recently published studies
[34–36]. Therefore, it could be argued that the eﬀects of cold
described herein may not be dependent on UCP2 regulation.
To provide further support to our hypothesis, we inhibited
UCP2 expression in cold-exposed/TNF-a-treated rats. This ap-
proach led to a complete reversal of the beneﬁcial eﬀects of
cold exposure on Bax, SOD and CAT.
In conclusion, the induction of UCP2 in the hypothalamus
of rats is an endogenous protective mechanism that minimizes
the harmful eﬀects of a potent inﬂammatory stimulus. The
modulation of UCP2 expression or activity may result in an
interesting therapeutic approach for inﬂammatory diseases of
the central nervous system.
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